Parthenon LLC Eli Lilly & CO Transaction History

Parthenon LLC

$822 Million
Q3 2024

A detailed history of Parthenon LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Parthenon LLC holds 5,667 shares of LLY stock, worth $4.35 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares

5,667

Previous 5,667 -0.0%

Holding current value

$4.35 Million

Previous $5.13 Million 2.14%

% of portfolio

0.61%

Previous 0.66%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$592.2 - $792.28 $58,035 - $77,643	-98 Reduced 1.7%	5,667 $4.41 Million
Q4 2023 Feb 05, 2024	BUY	$525.19 - $619.13 $51,468 - $60,674	98 Added 1.73%	5,765 $3.36 Million
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $80,453 - $94,488	-259 Reduced 4.37%	5,667 $1.95 Million
Q2 2022 Jul 29, 2022	SELL	$278.73 - $327.27 $10,034 - $11,781	-36 Reduced 0.6%	5,926 $1.92 Million
Q1 2021 Apr 23, 2021	BUY	$164.32 - $212.72 $24,483 - $31,695	149 Added 2.56%	5,962 $1.11 Million
Q4 2020 Feb 03, 2021	BUY	$130.46 - $172.63 $19,699 - $26,067	151 Added 2.67%	5,813 $981,000
Q4 2019 Jan 28, 2020	SELL	$106.92 - $132.43 $23,094 - $28,604	-216 Reduced 3.67%	5,662 $744,000
Q3 2019 Oct 31, 2019	SELL	$106.79 - $116.16 $13,882 - $15,100	-130 Reduced 2.16%	5,878 $657,000
Q1 2019 May 03, 2019	SELL	$111.31 - $131.02 $105,187 - $123,813	-945 Reduced 13.59%	6,008 $780,000
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $180,821 - $225,994	-2,106 Reduced 23.25%	6,953 $746,000
Q4 2017 Feb 06, 2018	SELL	$81.94 - $87.89 $9,832 - $10,546	-120 Reduced 1.31%	9,059 $765,000
Q3 2017 Oct 31, 2017	BUY	$77.07 - $85.54 $707,425 - $785,171	9,179	9,179 $785,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $730B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parthenon LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parthenon LLC with notifications on news.

Account